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Three scientists who developed therapies isolated from
natural sources against parasitic infections have won this
year’s Nobel Prize in Physiology or Medicine.
William C. Campbell, a microbiologist at Drew Uni-
versity in Madison, New Jersey and Satoshi Ōmura, a
microbiologist at Kitasato University in Japan isolated
avermectins from Streptomyces bacteria and tweaked the
structure of one of the most promising compounds to
develop it into a drug against onchocerciasis (river blind-
ness) — ivermectin.
The second half of the nobel pize was awarded for a
new plant-derived drug to Youyou Tu, a pharmacologist
at the China Academy of Chinese Medical Sciences in
Beijing. Tu, who won a Lasker prize in 2011, developed
the antimalarial drug artemisinin in the late 1960s and
1970s. She is the first China-based scientist to win a
Nobel prize in sciences.
In the 1960s, the main treatments for malaria were
chloroquine and quinine, but they were proving increas-
ingly ineffective. Diseases caused by parasites such as
malaria have been with humankind for millennia and
constitute a major global health problem affecting the
world’s poorest populations and represent a huge barrier
to improving human health and wellbeing. Malaria is a
mosquito-borne disease caused by single-cell parasites
infecting close to 200 million individuals yearly. The par-
asites invade red blood cells, causing fever, and in severe
cases brain damage and death. Malaria claims more than
450 000 lives, predominantly among children.
So in 1967, China established a national project against
malaria to discover new therapies. Tu and her team
screened more than 2,000 Chinese herbal remedies to
search for drugs with antimalarial activity. An extract from
the wormwood plant Artemisia annua proved especially
effective and by 1972, the researchers had isolated chem-
ically pure artemisin.
Artemisinin represents a new class of antimalarial agents
that rapidly kill the Malaria parasites at an early stage of
their development, which explains its unprecedented
potency in the treatment of severe Malaria. Nowadays, arte-
misinin is used in all Malaria-ridden parts of the world.
When used in combination therapy, it is estimated to re-
duce mortality from Malaria by more than 20 % overall and
by more than 30 % in children. For Africa alone, this means
that more than 100 000 lives are saved each year.
Thus, a plant-derived new drug has provided human-
kind with powerful new means to combat a debilitating
parasitic disease that affect hundreds of millions of
people annually. The consequences in terms of improved
human health and reduced suffering are immeasurable.
There is increased hope that phytomedicine will de-
liver additional new important discoveries that transform
the treatment of human diseases in the future.
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